# Corvus Pharmaceuticals, Inc.: filings

CRVS · Nasdaq · CIK 1626971 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crvs.md) · [Financials](/companies/crvs/financials.md) · [Filings](/companies/crvs/filings.md) · [Insiders](/companies/crvs/insiders.md)

## Reports and events: 201 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 224, 8-K 124, 10-Q 32, SC 13G/A 29, 3 25, SC 13G 13, SC 13D/A 12, 424B5 11, S-8 11, 10-K 10, DEF 14A 10, DEFA14A 10, CORRESP 9, SCHEDULE 13G/A 7, UPLOAD 7, EFFECT 5, S-3 4, SCHEDULE 13D/A 4, SC 13D 3, 10-K/A 2, 424B4 2, 5 2, CT ORDER 2, D 2, S-1/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 8-A12B 1, 8-K/A 1, CERTNAS 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, S-1 1, S-3/A 1, S-3ASR 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:04 ET | [10-Q](/filings/0001104659-26-091975.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091975 |
| 2026-08-06 | 16:02 ET | [8-K](/filings/0001171843-26-005317.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005317 |
| 2026-07-22 | 16:02 ET | [8-K](/filings/0001104659-26-085790.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-085790 |
| 2026-06-12 | 16:01 ET | [8-K](/filings/0001171843-26-004094.md) | 5.07 Shareholder vote results | 0001171843-26-004094 |
| 2026-05-14 | 07:01 ET | [8-K](/filings/0001171843-26-003397.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-003397 |
| 2026-05-07 | 16:05 ET | [10-Q](/filings/0001104659-26-057100.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057100 |
| 2026-05-07 | 16:01 ET | [8-K](/filings/0001171843-26-003154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003154 |
| 2026-04-24 | 16:15 ET | [DEF 14A](/filings/0001104659-26-048595.md) | Proxy statement, period 2026-06-11 | 0001104659-26-048595 |
| 2026-04-23 | 16:30 ET | [8-K](/filings/0001104659-26-047735.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-047735 |
| 2026-03-13 | 08:46 ET | [8-K](/filings/0001104659-26-027390.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-027390 |
| 2026-03-12 | 16:05 ET | [10-K](/filings/0001104659-26-027047.md) | Annual report, period 2025-12-31 | 0001104659-26-027047 |
| 2026-03-12 | 16:02 ET | [8-K](/filings/0001171843-26-001526.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001526 |
| 2026-02-05 | 10:29 ET | [SCHEDULE 13D/A](/filings/0001104659-26-010750.md) | Ownership report, active investor, amended | 0001104659-26-010750 |
| 2026-01-27 | 20:38 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000068.md) | Ownership report, active investor, amended | 0000947871-26-000068 |
| 2026-01-23 | 06:06 ET | [8-K](/filings/0001104659-26-005968.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-005968 |
| 2026-01-20 | 16:12 ET | [8-K](/filings/0001104659-26-005035.md) | 8.01 Other events | 0001104659-26-005035 |
| 2026-01-20 | 07:13 ET | [8-K](/filings/0001104659-26-004795.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-004795 |
| 2025-11-04 | 16:03 ET | [10-Q](/filings/0001104659-25-106259.md) | Quarterly report, period 2025-09-30 | 0001104659-25-106259 |
| 2025-11-04 | 16:01 ET | [8-K](/filings/0001171843-25-006973.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006973 |
| 2025-10-02 | 16:37 ET | [8-K](/filings/0001104659-25-096103.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-096103 |
| 2025-08-07 | 16:02 ET | [10-Q](/filings/0001558370-25-010755.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010755 |
| 2025-08-07 | 16:01 ET | [8-K](/filings/0001171843-25-005180.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005180 |
| 2025-06-13 | 16:02 ET | [8-K](/filings/0001171843-25-003881.md) | 5.07 Shareholder vote results | 0001171843-25-003881 |
| 2025-06-04 | 07:00 ET | [8-K](/filings/0001171843-25-003661.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-003661 |
| 2025-05-14 | 20:49 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000511.md) | Ownership report, active investor, amended | 0000947871-25-000511 |
| 2025-05-08 | 16:06 ET | [10-Q](/filings/0001558370-25-006966.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006966 |
| 2025-05-08 | 16:02 ET | [8-K](/filings/0001171843-25-002981.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002981 |
| 2025-05-01 | 21:20 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000444.md) | Ownership report, active investor, amended | 0000947871-25-000444 |
| 2025-04-25 | 16:02 ET | [DEF 14A](/filings/0001558370-25-005552.md) | Proxy statement, period 2025-06-12 | 0001558370-25-005552 |
| 2025-04-09 | 16:21 ET | [8-K](/filings/0001171843-25-002110.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-002110 |
| 2025-03-25 | 16:06 ET | [10-K](/filings/0001558370-25-003621.md) | Annual report, period 2024-12-31 | 0001558370-25-003621 |
| 2025-03-25 | 16:01 ET | [8-K](/filings/0001171843-25-001689.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001689 |
| 2025-01-13 | 07:30 ET | [8-K](/filings/0001558370-25-000150.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000150 |
| 2024-12-18 | 07:30 ET | [8-K](/filings/0001558370-24-016343.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016343 |
| 2024-11-12 | 16:03 ET | [10-Q](/filings/0001558370-24-015306.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015306 |
| 2024-11-12 | 16:02 ET | [8-K](/filings/0001171843-24-006284.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006284 |
| 2024-10-23 | 16:11 ET | [8-K](/filings/0001558370-24-013518.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-013518 |
| 2024-08-06 | 16:02 ET | [10-Q](/filings/0001558370-24-011076.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011076 |
| 2024-08-06 | 16:01 ET | [8-K](/filings/0001171843-24-004479.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004479 |
| 2024-06-14 | 16:15 ET | [8-K](/filings/0001171843-24-003444.md) | 5.07 Shareholder vote results | 0001171843-24-003444 |
| 2024-05-08 | 19:55 ET | [SC 13D/A](/filings/0000947871-24-000449.md) | Ownership report, active investor, amended | 0000947871-24-000449 |
| 2024-05-07 | 17:16 ET | [10-Q](/filings/0001558370-24-007093.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007093 |
| 2024-05-06 | 16:11 ET | [8-K](/filings/0001193125-24-131920.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-131920 |
| 2024-05-06 | 16:01 ET | [8-K](/filings/0001171843-24-002569.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002569 |
| 2024-05-01 | 17:06 ET | [8-K](/filings/0001193125-24-127611.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-127611 |
| 2024-04-26 | 16:05 ET | [DEF 14A](/filings/0001558370-24-005898.md) | Proxy statement, period 2024-06-13 | 0001558370-24-005898 |
| 2024-03-19 | 16:02 ET | [10-K](/filings/0001558370-24-003567.md) | Annual report, period 2023-12-31 | 0001558370-24-003567 |
| 2024-03-19 | 16:02 ET | [8-K](/filings/0001171843-24-001454.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001454 |
| 2024-01-23 | 17:00 ET | [8-K](/filings/0001171843-24-000360.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-000360 |
| 2023-11-07 | 16:03 ET | [8-K](/filings/0001171843-23-006818.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006818 |

Page 1 of 5. [Older](/companies/crvs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.